Alan Ho, MD/PhD

Dr. Alan Ho is an associate physician, serving as the chair of the Investigational New Drug (IND) committee at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Ho’s work focuses in the treatment of head and neck malignancies, specifically cancers of the salivary glands and thyroid. His experience as an MD/PhD enables him to translate novel therapeutics for cancer into the clinic as new drug therapies. Outside of his work at MSKCC, Dr. Ho helps promote the development of new oncology therapeutics in the head & neck field.

This work includes being a board member for the International Thyroid Oncology Group, chair of the head & neck subsection of the International Clinical Trials in Rare Cancer Initiative, lead of the head & neck working group in the Experimental Therapeutics Committee of the Alliance Cooperative Group, member of the National Comprehensive Cancer Network Investigator Steering Committee, and member of the NCI Head & Neck Steering Committee.